InsiderTrades

Form 4 for AMRX Amneal Pharmaceuticals, Inc.

Accepted 2022-03-03 00:00:00 ET · period of report 2022-03-01 · accession 0001209191-22-016055 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
DM 2022-03-03 2022-03-01 AMRX Shah Nikita EVP M - OptEx — +40.7K 274.0K +17% —
DM 2022-03-03 2022-03-01 AMRX Shah Nikita EVP F - Tax $4.45 -12.5K 265.1K -5% -$55.7K
DM 2022-03-03 2022-03-01 AMRX Shah Nikita EVP M - OptEx $0.00 -40.7K 86.9K -32% $0
DM 2022-03-03 2022-03-03 AMRX Shah Nikita EVP A - Grant $0.00 +434.8K 289.9K New $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Class A Common Stock 2022-03-01 M A 11,728 — 248,649 D — — (F1) Represents the gross number of shares of common stock awarded to the reporting person in connection with the vesting of restricted stock units. The actual number of shares issued was reduced by the number of shares withheld to satisfy tax withholding obligations. See footnote 3. (F2) Each restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock.
2 Common Class A Common Stock 2022-03-01 F D 3,607 $4.45 245,042 D — — (F3) Represents shares of common stock withheld to satisfy tax withholding obligations relating to the vesting of restricted stock units.
3 Common Class A Common Stock 2022-03-01 M A 28,957 — 273,999 D — — (F1) Represents the gross number of shares of common stock awarded to the reporting person in connection with the vesting of restricted stock units. The actual number of shares issued was reduced by the number of shares withheld to satisfy tax withholding obligations. See footnote 3. (F2) Each restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock.
4 Common Class A Common Stock 2022-03-01 F D 8,905 $4.45 265,094 D — — (F3) Represents shares of common stock withheld to satisfy tax withholding obligations relating to the vesting of restricted stock units.
5 Derivative Restricted Stock Units 2022-03-01 M D 11,728 $0.00 11,729 D — · — to — 11,728 Class A Common Stock (F2) Each restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock. (F4) On March 1, 2019, the reporting person was granted 46,914 restricted stock units, vesting in four equal installments beginning on the first anniversary of the grant date.
6 Derivative Restricted Stock Units 2022-03-01 M D 28,957 $0.00 86,873 D — · — to — 28,957 Class A Common Stock (F2) Each restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock. (F5) On March 1, 2021, the reporting person was granted 115,830 restricted stock units, vesting in four equal installments beginning on the first anniversary of the grant date.
7 Derivative Restricted Stock Units 2022-03-03 A A 144,928 $0.00 144,928 D — · — to — 144,928 Class A Common Stock (F2) Each restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock. (F6) The restricted stock units vest in four equal annual installments beginning on March 3, 2023.
8 Derivative Performance-Based Restricted Stock Units 2022-03-03 A A 289,856 $0.00 289,856 D — · — to — 289,856 Class A Common Stock (F8) Represents a performance-based restricted stock unit grant of 144,928 target shares. The performance-based restricted stock units are scheduled to vest based on the Issuer's Class A Common Stock achieving certain average closing prices per share over a three-year performance period. The number of performance-based restricted stock units reported represents the maximum number of shares issuable under the award. The number that would be received upon vesting, if any, may vary from 0% to 200% of the target number. The number of performance-based restricted stock units reported in the table above represents the maximum number of shares issuable under the award. Any earned performance-based restricted stock units vest in full on February 28, 2025, the last day of the performance period. (F7) Each performance-based restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock.